Track Categories

The track category is the heading under which your abstract will be reviewed and later published in the conference printed matters if accepted. During the submission process, you will be asked to select one track category for your abstract.

Neurocardiology is a branch of cardiology that includes the neurophysiological, neuroanatomical, and neurological aspects.
It primarily includes the neurological causes of cardiac disorders.
It is investigated in terms of heart interactions with the central and peripheral nervous systems.
Cardiovascular intervention and findings are two clinical issues in neurocardiology.
A brief neuron intervention that can result in arrhythmias and heart failure.

Neuro oncology: This specialty deals with brain and spinal cord neoplasms, which are the most life threatening and dangerous.
The worst malignancy brain cancers are gliomas of the brainstem and pons, glioblastoma multiforme, and high grade astrocytoma.
Survival without treatment is usually limited to a few months, whereas survival with radiation and chemotherapy treatment can last a year or more depending on the immune system.

  • Track 1-1Cardiovascular Systems
  • Track 1-2Neurocardiac Axis Link
  • Track 1-3Cardiovascular Systems
  • Track 1-4Brain and Spinal cord Neoplasms
  • Track 1-5Neurological Tumors

Cardiology is a discipline of medicine that focuses on disorders with the heart and other components of the circulatory system. Congenital heart defects, coronary artery disease, heart failure, valvular heart disease, and electrophysiology are all included in this field.

Cardiologists, a subspecialty of internal medicine, are doctors who specialize in this branch of medicine. Pediatric cardiologists are cardiology-focused physicians. Cardiothoracic surgeons, often known as cardiac surgeons, are general surgery specialists who specialize in cardiac surgery.

  • Track 2-1Congenital heart defects
  • Track 2-2Coronary artery disease
  • Track 2-3Heart failure
  • Track 2-4Valvular heart disease
  • Track 2-5Electrophysiology

Technology to help patients with arrhythmia disorders control their diseases is growing at such a fast rate that concepts that seemed impossible only a few years ago are already a reality.

Leadless pacemakers, subcutaneous implantable cardioverter defibrillators, subcutaneous implantable loop recorders, and methods to make ablation more effective are among the innovative technology new to the market or in clinical testing.

  • Track 3-1Tachycardia
  • Track 3-2Bradycardia
  • Track 3-3Supraventricular arrhythmias
  • Track 3-4Ventricular arrhythmias
  • Track 3-5Bradyarrhythmias

Calcium buildup during a major artery outside the guts may indicate a future attack or stroke. According to researchers, People with abdominal aortic calcification (AAC) have a two to four times increased risk of a future cardiovascular incident. The study also discovered that the more calcium in the blood vessel wall, the higher the chance of future cardiovascular events, and that persons with AAC and chronic kidney illness were at an even higher risk than those without AAC.

Calcium can build up in the blood vessel wall and harden the arteries, obstructing blood flow or causing plaque rupture, both of which are common causes of heart attacks and strokes.

Poor diet, a sedentary lifestyle, smoking, and genetics are all factors that contribute to arterial calcification.

  • Track 4-1Coronary Artery Disease
  • Track 4-2Heart Arrhythmias
  • Track 4-3Heart failure
  • Track 4-4Heart Valve Disease
  • Track 4-5Pericardial Disease
  • Track 4-6Cardiomyopathy
  • Track 4-7Congenital Heart Disease

Hypertension may be a major risk factor for heart condition and stroke. Around a third of people with hypertension are now undiagnosed, and half of those who have been identified are not taking antihypertensive drugs. The World Health Organization (WHO) estimates that high blood pressure kills at least nine million people worldwide each year, either directly or indirectly.

Our goal is to highlight recent advances in hypertension clinical and basic research, as well as to discuss future paths in the discipline's development and building.

  • Track 5-1Hypertension-overview
  • Track 5-2Hypertensive heart disease
  • Track 5-3Primary and secondary high blood pressure
  • Track 5-4High blood pressure treatments
  • Track 5-5High blood pressure medications

Because of its rising prevalence, severe morbidity, high mortality, and fast rising health-care costs, heart failure (HF) is a major cardiovascular illness. The number of people suffering with Heart failure is rising all over the world. Over the last four decades, there have been significant advancements in the definition, diagnostic methods, and management of Heart failure. Biomarkers, imaging, and genetic testing are all being used to improve HF risk categorization.

In clinical practise, newly innovative drugs and equipment for HF have been widely accepted. In addition, final treatment for end-stage heart failure, such as a left ventricular assist device or heart transplantation, is fast evolving.

  • Track 6-1Atrial Fibrillation
  • Track 6-2Device Therapy
  • Track 6-3Chronic Heart Failure
  • Track 6-4Acute Heart Failure
  • Track 6-5Valvular Heart Disease
  • Track 6-6Acute Cardiac Care

Evolved cardiac imaging has advanced greatly as a result of technological improvements, and it now serves as both a diagnostic and a prognostic tool. Regular follow-up imaging, such as echocardiography or more advanced imaging, such as stress imaging, is required for patients with heart failure.

Imaging-guided treatment and interventional procedures help patients with heart failure. The purpose of this research is to provide a comprehensive overview of the most recent imaging modalities for heart failure diagnosis and treatment.

  • Track 7-1Artificial Intelligence
  • Track 7-2CT Imaging
  • Track 7-3CT Calcium Scoring Now Part of Guidelines
  • Track 7-4Important Cardiology Articles
  • Track 7-5New Cardiac CT scanner Technology
  • Track 7-6Advances in Spectral Imaging
  • Track 7-7Special Sessions for EP and Structural Heart

Progress has been made in research on innovative treatments, mechanical and pharmacological approaches, and repair/regenerative cellular therapy to treat irreversible cardiovascular illnesses such as myocardial infarction. In cellular therapy research, new cellular types are being researched. Although the therapeutic effects of cell therapy are still limited, clinical trial results are encouraging.

This advancement is being aided by advances in stem cell paracrine activity, the use of growth factors, miRNA, and novel biomaterials. In the near future, these therapies should become commonplace in clinical practise.

  • Track 8-1Percutaneous coronary intervention
  • Track 8-2Coronary artery bypass grafting
  • Track 8-3primary coronary event, such as plaque rupture
  • Track 8-4A problem of oxygen supply and demand
  • Track 8-5Sudden cardiac death

Pulmonary hypertension is difficult to spot early because it's rarely discovered during a typical physical examination. Even when the disease has progressed, the signs and symptoms are identical to those of other heart and lung diseases.

The field of pulmonary arterial hypertension (PAH) has recently been marked by significant advances in therapy alternatives and, as a result, improved patient outcomes. Our goal is to bring out the latest developments in the treatment of pulmonary heart diseases.

  • Track 9-1Dyspnea
  • Track 9-2Pulmonary Embolism
  • Track 9-3Hypercapnia
  • Track 9-4Obstructive Sleep Apnea
  • Track 9-5Chronic Obstructive Pulmonary Disease
  • Track 9-6Hypoxemia
  • Track 9-7Hypoxemia
  • Track 9-8Heart Failure

The most common cause of death in the world is coronary artery disease (CAD). While the symptoms and signs of coronary artery disease are recognised in advanced stages of the disease, most people with the disease show no signs or symptoms for decades as the disease advances before the first manifestation of symptoms, which is typically a "sudden" heart attack, occurs.

Some of these atheromatous plaques may rupture after decades of growth, reducing blood supply to the heart muscle (along with the activation of the blood clotting system). The disease is the leading cause of sudden death, as well as the leading cause of death in men and women over the age of 20.

Individuals with this level of coronary artery disease have often had one or more myocardial infarctions (heart attacks) and may be experiencing signs and symptoms of persistent coronary ischemia, such as angina at rest and flash pulmonary edema.

  • Track 10-1Obstructive coronary artery disease
  • Track 10-2Non-obstructive coronary artery disease
  • Track 10-3Coronary micro vascular disease
  • Track 10-4Coronary Artery Bypass Surgery
  • Track 10-5High blood pressure

Cardiovascular diseases (CVDs) are the leading cause of death worldwide, claiming the lives of an estimated 17.9 million people per year. Coronary heart disease, cerebrovascular illness, rheumatic heart disease, and other heart and blood vessel problems are all classified as CVDs. Heart attacks and strokes account for more than four out of every five CVD deaths, with one-third of these deaths occurring before the age of 70.

A variety of laboratory tests and imaging examinations are used to diagnose cardiovascular disorders. The medical and family histories of the patient, risk factors, physical examination, and synchronisation of these findings with the results of tests and procedures are the most important aspects of diagnosis.

  • Track 11-1Abnormal heart rhythms or arrhythmias
  • Track 11-2Congenital heart disease
  • Track 11-3Deep vein thrombosis
  • Track 11-4Pulmonary embolism
  • Track 11-5Heart muscle disease

For women, heart disease is the main cause of death. Heart disease affects women in various ways than it does males. Men, for example, have more heart attacks than women, but women die from heart attacks at a higher rate than men. During percutaneous coronary interventions (PCI) using femoral arterial access, women have a greater rate of bleeding. Drug-induced cardiac arrhythmias are also more common in women.

The completed studies have contributed to the establishment of guiding documents for drug and device development for men and women, as well as a better knowledge of cardiovascular disease in women.

  • Track 12-1Anxiety and Heart Disease
  • Track 12-2Assessing Cardiovascular Risk with C-Reactive Protein
  • Track 12-3Depression and Heart Disease
  • Track 12-4Menopause and the Cardiovascular System
  • Track 12-5Peripartum Cardiomyopathy
  • Track 12-6Diabetes and Heart Disease in Women
  • Track 12-7New Imaging Techniques: Risks and Benefits
  • Track 12-8Vitamin D and the Heart

Every day, improvements in the field of heart surgery are created. Surgery is becoming easier and safer, and recovery is becoming faster and less painful, due to advances in technology. New and creative techniques for minimally invasive operations, cutting-edge technologies, and clinical trials are all helping to advance the science of heart surgery in Beaumont, reducing recovery periods and making heart surgery less painful for patients.

With the introduction of newer immunosuppressive drugs and procedures that may potentially result in tolerance, the future of heart transplantation seems bright. A improved knowledge of acute and chronic rejection pathways through basic science investigations supports much of this improvement in heart transplant treatment. Personalized medicine will be a part of the future, with genetics and molecular research dictating specific treatment for best results.

  • Track 13-1Coronary artery bypass grafting
  • Track 13-2Heart valve repair or replacement
  • Track 13-3Insertion of a pacemaker or an implantable cardioverter defibrillator
  • Track 13-4Maze surgery
  • Track 13-5Aneurysm repair
  • Track 13-6Heart transplant
  • Track 13-7Insertion of a ventricular assist device (VAD) or total artificial heart (TAH)

For the assessment of patients with valvular heart disease, echocardiography is the preferred imaging modality. Advances in echocardiography may have a significant impact on the assessment and treatment of individuals with valvular heart disease.

This review will highlight the current research on improvements in this patient population, including three-dimensional echocardiography, strain imaging, intracardiac echocardiography, and fusion imaging.

  • Track 14-1Cardiomyopathies
  • Track 14-2Diseases of the aorta
  • Track 14-3Transesophageal echocardiography
  • Track 14-4Stress echo echocardiography
  • Track 14-5Computed tomography

Clinical cardiology is a specialty of medicine that focuses on the diagnosis and treatment of cardiovascular disorders. Interventional cardiology, cardiac electrophysiology, echocardiography, and nuclear cardiology are all common specialties for cardiologists. When it comes to cardiac diseases, each of these specialty has its own set of techniques.

This session will have a big impact on cardiac research in the future. Cardiology is the study of heart diseases and disorders such coronary artery disease and congestive heart failure. Congenital heart defects, coronary artery disease, heart failure, vascular heart disease, and electrophysiology are all covered within clinical cardiology.

  • Track 15-1Acute Coronary Syndromes
  • Track 15-2Heart Failure and Cardiomyopathies
  • Track 15-3Geriatric Cardiology
  • Track 15-4Arrhythmias and Clinical EP
  • Track 15-5Invasive Cardiovascular Angiography and Intervention
  • Track 15-6Valvular Heart Disease

By providing their important clinical examples of late occurrence, cardiology case reports provide an ideal assemblage for all cardiologists. Clinicians, students, and paramedical staff members gain significant experience through studying medical cases.

Rare medical reports and conditions uncovered using cutting-edge examination techniques are supported. Furthermore, studying diagnostic procedures from medical cases and symptom interpretation is important for training and improving the processes employed in the clinical field.

  • Track 16-1Case reports on Cardiac surgery
  • Track 16-2Case reports on Vascular heart disease
  • Track 16-3Case reports on Hypertension and Healthcare
  • Track 16-4Case reports on Cardiac and Cardiovascular research
  • Track 16-5Case reports on Pediatric Cardiology
  • Track 16-6Case reports on Heart diagnosis
  • Track 16-7Case reports on Heart disease & Failure
  • Track 16-8Case reports on Atherosclerosis
  • Track 16-9Case reports on Heart devices

Interventional cardiology could also be a rapidly expanding specialty. This expansion is thanks to advancements in existing technology, the creation of the latest technologies, and thus the extension of patient selection criteria.

Recent randomized studies examining the efficacy of revascularization or medical treatment in stable ischemic heart disease, the treatment of acute coronary syndromes, emerging interventional devices, adjunctive pharmacotherapy, and intravascular imaging and physiology guidance have advanced the evidence-based knowledge in interventional cardiology significantly.

  • Track 17-1Ischemic heart diseases
  • Track 17-2Angiogram
  • Track 17-3Angioplasty
  • Track 17-4Disorders of heart valves
  • Track 17-5Valvuloplasty

In the past year, significant progress has been made in the field of paediatric cardiology, Several clinical studies and the issuance of expert understandings in various subspecialties proving to be invaluable in improving the diagnosis and treatment of cardiovascular disease in children.

Paediatric cardiology is concerned with cardiac disorders in children who are still growing and developing. In order to provide all-around patient care, paediatric cardiologists need a strong background in general paediatrics as well as knowledge in cardiac disease.


  • Track 18-1Fetal cardiology
  • Track 18-2Arrhythmias
  • Track 18-3Pediatric cardiac imaging
  • Track 18-4Multicenter heart failure
  • Track 18-5Quality Improvement

Cardiovascular pharmacotherapy is still a very active field. The goal of this study is to outline recent key breakthroughs in cardiovascular pharmacotherapy, with an emphasis on a recently approved medicine for heart failure treatment.

Heart failure is a prominent cause of morbidity and mortality globally, despite all breakthroughs in pharmacological and therapeutic treatment. To treat heart failure, many new therapeutic advance tactics have been investigated, including cell transplantation, gene delivery or therapy, and cytokines or other small chemicals.

  • Track 19-1Cotransporter
  • Track 19-2Endothelial Progenitor Cell
  • Track 19-3Blood Pressure
  • Track 19-4Actinobacteria
  • Track 19-5Leporidae

Artificial intelligence, digital health technology, and mobile devices will transform cardiovascular care in the future as a way to prevent and treat heart disease.

The heart's sound, rhythm, pace, structure, and function are all monitored in order to maintain it healthy for as long as feasible. To prevent stroke, heart attack, heart failure, or any other cardiovascular risk, an army of digital health technology has recently joined forces with traditional cardiology preventive techniques. Miniature sensors, digital twins, and artificial intelligence could help them in the future.

Let's take a look at what the future of cardiology may hold!

  • Track 20-1Innovative imaging and device technologies
  • Track 20-2Surgical and interventional approaches
  • Track 20-3New diagnostic methods, screening, and patient classification are all being explored.
  • Track 20-4Cardiology personalised medication
  • Track 20-5Therapeutic overviews showcasing the best treatment options and future possibilities
  • Track 20-6Evidence from the real world and outcomes research

Heart disease is treated with a variety of medications. It's crucial for persons with heart disease and those who care for them to understand their medications, read the labels, and be aware of any potential side effects.

Physical examination findings, interviews with the patient and his or her family, a patient's and family history, and clinical findings in laboratory and radiographic examinations are all used to make a medical diagnosis. Imaging techniques, surgery, electrophysiology, angiography, radiography, and other approaches can all be used to diagnose cardiac disease. Following a heart disease diagnosis, hospital treatment is essential.

  • Track 21-1Echocardiogram
  • Track 21-2Cardiac Catheterization
  • Track 21-3Electrophysiology Test
  • Track 21-4CT Heart Scan
  • Track 21-5Myocardial Biopsy
  • Track 21-6Pericardiocentesis

Heart failure and death are caused by the heart's limited regeneration capacity. It's difficult for cardiac cells to recover once they've been diseased, similar to how your body would heal a wound. For researchers interested in creating and regenerating heart cells, studying how the heart develops in babies and then adults is a natural next step.

They're also looking into how stem cell-derived cardiac cells heal damaged hearts and whether they may be used to treat heart muscle problems.


  • Track 22-1Adult stem cells
  • Track 22-2Pluripotent stem cells
  • Track 22-3Cardiac Stem-Ness
  • Track 22-4Applications of PSCs in cardiovascular research
  • Track 22-5Translational potential of PSC
  • Track 22-6Pluripotent stem cells in first human trials